| Senanarong V, Poungvarin N, Phanthumchinda K, et al.
Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients. [Journal Article, Research Support, Non-U.S. Gov't]
J Med Assoc Thai 2009 Mar.:S12-8.
Abstract | Full Citation | | Rozzini L, Vicini Chilovi B, Conti M, et al.
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. [JOURNAL ARTICLE]
Int Psychogeriatr 2009 Jun 25.:1-6.
Abstract | Full Citation | Find Related Articles | | Herrmann N, Binder C, Dalziel W, et al.
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study. [Journal Article]
Drugs Aging 2009; 26(5):403-7.
Abstract | Full Citation | Find Related Articles | | Rockwood K, Fay S, Gorman M
The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease. [JOURNAL ARTICLE]
Int J Geriatr Psychiatry 2009 Jun 22.
Abstract | Full Citation | Find Related Articles | | Rodda J, Morgan S, Walker Z
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. [JOURNAL ARTICLE]
Int Psychogeriatr 2009 Jun 19.:1-12.
Abstract | Full Citation | Find Related Articles | | Bokde AL, Karmann M, Teipel SJ, et al.
Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Psychopharmacol 2009 Apr; 29(2):147-56.
Abstract | Full Citation | Find Related Articles | | Franke AG, Lieb K, Fellgiebel A
From Symptomatic to Disease Modifying Therapy? [JOURNAL ARTICLE]
Fortschr Neurol Psychiatr 2009 Jun; 77(6):326-333.
Abstract | Full Citation | | Takeda S, Sato N, Niisato K, et al.
Validation of Abeta1-40 Administration into Mouse Cerebroventricles as an Animal Model for Alzheimer Disease. [JOURNAL ARTICLE]
Brain Res 2009 May 20.
Abstract | Full Citation | Find Related Articles | | Muthuraju S, Maiti P, Solanki P, et al.
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. [JOURNAL ARTICLE]
Behav Brain Res 2009 Mar 28.
Abstract | Full Citation | | Venneri A, Lane R
Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease. [Journal Article, Research Support, Non-U.S. Gov't]
Neuroreport 2009 Feb 18; 20(3):285-8.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
